Rapid microbial method for rapid sterility testing for sterile injectables and other pharmaceutical products
Featured Story

Pfizer’s Implementation of a Rapid Sterility Method

From Bold Idea to Completed Project in Record Time

Joanny Salvas, Senior Manager of Global Technology and Engineering at Pfizer, presented her experience with implementing a Celsis® ATP bioluminescence-based rapid sterility test method at the PDA 2021 Pharmaceutical Microbiology Conference.

Pfizer’s goal was to create a sterile injectable and quickly release it for global deployment, all without risking patient safety. They turned to Celsis® ATP bioluminescence technology to test their product for sterility and Charles River helped them create a strategy to streamline their validation timeline. Through this partnership, Pfizer was able to expedite the system validation to a mere nine-and-a-half-months.

Read the Full Story